Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
Clinical trial NCT04414631 · TERMINATED
Trial details
- NCT number
- NCT04414631
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-06
- Primary completion
- 2021-09-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.